Avelios
+183%
est. 2Y upside i
Avelios is a modern and modular hospital information system bringing together documentation, administration, patient portals, AI solutions and more.
Rank
#66
Sector
Healthtech
Est. Liquidity
~4Y
Data Quality
Data: MediumAvelios offers a strong growth narrative with a modern HIS platform, but the equity case is tempered by high incumbent threat and limited near-term liquidity.
Last updated: July 19, 2026
Multiple holds at 8x due to successful IPO window or category leadership; projected revenue $53.3M yields exit value $426M, net of 20% dilution.
Multiple converges to 6x, consistent with public comps; exit value $320M, net of 20% dilution.
Multiple compresses to 3x due to incumbent competition and slower growth; exit value $160M, net of 20% dilution, preference stack not triggered.
Preference Stack Risk
severeFunding Intensity
114%Total funding of $33.3M represents 38% of current valuation, indicating severe preference overhang.
Dilution Risk
highLikely need for additional capital within 24 months given burn rate and early stage.
Secondary Liquidity
noneNo secondary market activity observed; IPO or acquisition needed for liquidity.
Questions to Ask at the Interview
Strategic questions based on Avelios's data — designed to show you've done your homework.
- 1
“How do you plan to differentiate against Epic and Cerner's installed base over the next 2 years?”
- 2
“What is the path to profitability given the current burn rate and subscription model?”
- 3
“What is the expected timeline for an IPO or acquisition, and how does that align with employee liquidity?”
Community
Valuation Sentiment
Our model estimates +183% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.